Revolade shows long-term disease control for immune thrombocytopenia
Novartis has announced long-term study results supporting the positive safety and efficacy of Revolade in adults with chronic/persistent immune thrombocytopenia...
List view / Grid view
News
Arsenic identified as a potential treatment for brain cancer
Arsenic trioxide could extend the survival of glioblastoma patients by three to four times the historic median...
Oral semaglutide shows promise for type 2 diabetes
Researchers have identified that the drug semaglutide resulted in better glycemic control than placebo for patients with type 2 diabetes...
DOACs used as a alternative to warfarin to treat venous thromboembolism
A study has found that a new group of drugs used to treat patients with serious blood clots are not associated with a higher risk of major bleeding compared with warfarin...
Flu vaccine found to be ineffective in leukaemia patients
Leukaemia patients who were vaccinated against influenza were just as likely as their unvaccinated peers to develop flu, suggesting that additional steps are necessary to protect high-risk individuals...
Macrophages play critical role in sustained delivery of MD therapy
Inflammatory cells retain drug after it disappears from circulation, improving delivery to regenerating muscle cells...
Janssen announces FDA approval of Stelara for plaque psoriasis
The FDA has approved an expanded indication for Stelara for the treatment of adolescents with moderate plaque psoriasis...
Experimental Ebola vaccines elicit year-long immune response
Clinical trial results show that two candidate Ebola vaccines can elicit immune responses after initial vaccination that last for at least one year...
Experimental nano-chemo particle to treat bladder cancer
Researchers have developed a way to successfully deliver nano-sized, platinum-based chemotherapy drugs to treat a form of bladder cancer...
NIH launches $215m partnership for cancer immunotherapy strategies
The NIH and 11 leading biopharmaceutical companies have launched the Partnership for Accelerating Cancer Therapies (PACT), totalling $215m as part of the Cancer Moonshot....
PI3K inhibitors show hope for rare bone cancers
Scientists have used genome sequencing to gain a better understanding of the biology underlying chordoma...
Polyphor launches the development of an inhaled antibiotic murepavadin
Polyphor Ltd has announced €5m funding, in order to support and accelerate the development of an inhaled dosage form of murepavadin...
Rapamycin treatment prevents crippling heterotopic ossification
FDA-approved drug holds promise for first effective treatment to prevent trauma-induced heterotopic ossification formation...
Neratinib defeats the Ras genes notorious for causing cancer
Breast cancer drug neratinib has been found to block the function of the Ras genes which are among the first to be linked to cancer development...
Join Dolomite Bio at ASHG 2017
Dolomite Bio is set to display its innovative range of products for high throughput single cell research at the 67th Annual Meeting of the American Society of Human Genetics (ASHG), taking place at the Orange County Convention Center in Orlando, Florida, from the 17th to the 21st of October 2017...
